Lactoferrin (LF) is an iron-binding protein found in mucosal secretions, tears, breast milk, and neutrophils. It has well- characterized bacteriostatic and bactericidal activity and has been suggested to play a role in protecting mucosal membranes and breast-fed infants from infection. Preliminary studies suggest that LF exerts an antiviral effect as well. This proposal will characterize the inhibitory effect of Lf on herpes simplex virus, type 1. LF binding to the virus will be investigated, and the specific site and mechanism of antiviral activity will be determined. The effect of Lf on virus-infected cells will be studied. In addition, the contribution of Lf to the antiviral properties of mucosal secretions (saliva in this study) will be evaluated. Lf will be tested in combination with other antimicrobial salivary proteins for a possible synergistic antiviral effect. Finally, Lf will be tested against other viruses in order to gain an idea of the spectrum of Lf antiviral activity. As a result of this investigation, a newly described antimicrobial effect of Lf will be characterized and will be suggestive of another mechanism of innate immunity against infection. In addition, this investigation will provide scientific training for a doctoral graduate student and an opportunity to present his/her research at a national science meeting and submit at least one paper for publication.

Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
1996
Total Cost
Indirect Cost
Wilson, Nana O; Solomon, Wesley; Anderson, Leonard et al. (2013) Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria. PLoS One 8:e60898
Igietseme, Joseph U; Omosun, Yusuf; Partin, James et al. (2013) Prevention of Chlamydia-induced infertility by inhibition of local caspase activity. J Infect Dis 207:1095-104
Wilson, Nana; Driss, Adel; Solomon, Wesley et al. (2013) CXCL10 gene promoter polymorphism -1447A>G correlates with plasma CXCL10 levels and is associated with male susceptibility to cerebral malaria. PLoS One 8:e81329
Kim, Teayoun; Zhelyabovska, Olga; Liu, Jian et al. (2013) Generation of an inducible, cardiomyocyte-specific transgenic mouse model with PPAR ?/? overexpression. Methods Mol Biol 952:57-65
Shelton, Martin N; Huang, Ming-Bo; Ali, Syed A et al. (2012) Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release. J Virol 86:406-19
Campbell, Patrick E; Isayev, Olexandr; Ali, Syed A et al. (2012) Validation of a novel secretion modification region (SMR) of HIV-1 Nef using cohort sequence analysis and molecular modeling. J Mol Model 18:4603-13
Liu, Mingli; Amodu, Audu S; Pitts, Sidney et al. (2012) Heme mediated STAT3 activation in severe malaria. PLoS One 7:e34280
Wilson, Nana O; Ceesay, Fatou K; Hibbert, Jacqueline M et al. (2012) Pregnancy outcomes among patients with sickle cell disease at Korle-Bu Teaching Hospital, Accra, Ghana: retrospective cohort study. Am J Trop Med Hyg 86:936-42
Wilson, Nana O; Ceesay, Fatou K; Obed, Samuel A et al. (2011) Intermittent preventive treatment with sulfadoxine-pyrimethamine against malaria and anemia in pregnant women. Am J Trop Med Hyg 85:12-21
Lucchi, Naomi W; Jain, Vidhan; Wilson, Nana O et al. (2011) Potential serological biomarkers of cerebral malaria. Dis Markers 31:327-35

Showing the most recent 10 out of 122 publications